Literature DB >> 30151653

Interactions between Helicobacter pylori and gastroesophageal reflux disease.

Oya Yucel1.   

Abstract

Interactions between Helicobacter Pylori (HP) and gastroesophageal reflux disease (GERD) are a complex issue. Several pathophysiological factors influence the development and the course of GERD, HP infection might be only one of these. Many studies emphasize the co-existence of these diseases. HP infection could contribute to GERD through both a protective and an aggressive role. Gastric acid secretion is a key factor in the pathophysiology of reflux esophagitis. Depending on the type of gastritis related to HP, acid secretion may either increase or decrease. Gastritis in corpus leads to hypoacidity, while antrum gastritis leads to hyperacidity. In cases of antral gastritis and duodenal ulcers which have hyperacidity, the expectation is an improvement in pre-existing reflux esophagitis after eradication of HP. In adults, HP infection is often associated with atrophic gastritis in the corpus. Atrophic gastritis may protect against GERD. Pangastritis which leads to gastric atrophy is commonly associated with CagA strains of HP and it causes more severe gastric inflammation. In case of HP-positive corpus gastritis in the stomach, pangastritis, and atrophic gastritis, reflux esophagitis occurs frequently after eradication of HP. Nonetheless, as a predisposing disease of gastric cancer, HP should be treated. In conclusion, as the determinative factors affecting GERD involving in HP, detailed data on the location of gastric inflammation and CagA positivity should be obtained by the studies at future.

Entities:  

Keywords:  CagA; Children; Gastritis; Gastroesophageal reflux; Helicobacter pylori

Mesh:

Substances:

Year:  2018        PMID: 30151653     DOI: 10.1007/s10388-018-0637-5

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  88 in total

1.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.

Authors:  J Labenz; A L Blum; E Bayerdörffer; A Meining; M Stolte; G Börsch
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Helicobacter pylori and gastroesophageal reflux disease: a complex organism in a complex host.

Authors:  Werner Schwizer; Mark Fox
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

Review 3.  Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.

Authors:  Mitsushige Sugimoto; Takahiro Uotani; Hitomi Ichikawa; Akira Andoh; Takahisa Furuta
Journal:  Digestion       Date:  2016-01-14       Impact factor: 3.216

4.  Corpus gastritis is protective against reflux oesophagitis.

Authors:  H B El-Serag; A Sonnenberg; M M Jamal; J M Inadomi; L A Crooks; R M Feddersen
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

5.  Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion.

Authors:  T Koike; S Ohara; H Sekine; K Iijima; Y Abe; K Kato; T Toyota; T Shimosegawa
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

6.  Manometric and pH-metric features in gastro-oesophageal reflux disease patients with and without Helicobacter pylori infection.

Authors:  G Manes; P Esposito; M Lioniello; A Bove; S Mosca; A Balzano
Journal:  Dig Liver Dis       Date:  2000 Jun-Jul       Impact factor: 4.088

7.  Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?

Authors:  C A Fallone; A N Barkun; G Friedman; S Mayrand; V Loo; R Beech; L Best; L Joseph
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

8.  Helicobacter pylori infection and gastroesophageal reflux in children.

Authors:  V V Lupu; A Ignat; G Ciubotariu; A Ciubară; M Moscalu; M Burlea
Journal:  Dis Esophagus       Date:  2015-10-12       Impact factor: 3.429

9.  Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

10.  Helicobacter pylori and gastroesophageal reflux disease.

Authors:  Michele Grande; Federica Cadeddu; Massimo Villa; Grazia Maria Attinà; Marco Gallinella Muzi; Casimiro Nigro; Francesco Rulli; Attilio M Farinon
Journal:  World J Surg Oncol       Date:  2008-07-05       Impact factor: 2.754

View more
  6 in total

1.  Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm: a single-center prospective study.

Authors:  Hee Kyong Na; Jeong Hoon Lee; Se Jeong Park; Hee Jung Park; Sun Ok Kim; Ji Yong Ahn; Do Hoon Kim; Kee Wook Jung; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  BMC Gastroenterol       Date:  2020-04-21       Impact factor: 3.067

Review 2.  Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review.

Authors:  Lu Han; Xu Shu; Jian Wang
Journal:  Front Microbiol       Date:  2022-02-08       Impact factor: 5.640

3.  The association between helicobacter pylori infection and erosive gastroesophageal reflux disease; a cross-sectional study.

Authors:  Ramin Niknam; Kamran Bagheri Lankarani; Mohsen Moghadami; Seyed Alireza Taghavi; Leila Zahiri; Mohammad Javad Fallahi
Journal:  BMC Infect Dis       Date:  2022-03-19       Impact factor: 3.090

4.  Inverse correlation between gastroesophageal reflux disease and atrophic gastritis assessed by endoscopy and serology.

Authors:  Yoo Min Han; Su Jin Chung; Seokha Yoo; Jong In Yang; Ji Min Choi; Jooyoung Lee; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2022-02-28       Impact factor: 5.742

5.  Definition of Mucosal Breaks in the Era of Magnifying Endoscopy with Narrow-Band Imaging.

Authors:  Daisuke Kikuchi; Hiroyuki Odagiri; Yoshio Hoshihara; Yorinari Ochiai; Yugo Suzuki; Junnosuke Hayasaka; Masami Tanaka; Kosuke Nomura; Satoshi Yamashita; Akira Matsui; Toshiro Iizuka; Shu Hoteya
Journal:  Gastroenterol Res Pract       Date:  2022-05-13       Impact factor: 2.260

6.  Dabigatran-induced esophagitis: A case report.

Authors:  Yi Zhou; Yancheng Dai; Lei Lu; Zhiquan Fu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.